戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 andidates, and provides a convenient monthly administration schedule.
2 ee times weekly for 4 weeks using a standard administration schedule.
3 plastic agents but was highly dependent upon administration schedule.
4 safety profile of the implant over the fixed administration schedule.
5 were very stable and independent of the self-administration schedule.
6 cal in packaging, labelling, appearance, and administration schedule.
7 with depsipeptide should examine alternative administration schedules.
8 al, dictated a change in dose escalation and administration schedules.
9 natomic regions, risk levels, and antiemetic administration schedules.
10 with allowance for evaluation of alternative administration schedules.
11 h favorable toxicity profiles and convenient administration schedules.
12 n with WT is no less effective than the long administration schedule and can be administered at a sub
13                                              Administration schedule and dose of Synthokine were eval
14  competition, countries' ability to pay, the administration schedule, and the availability of policie
15 d for cold-chain distribution, a prime-boost administration schedule, and the emergence of variants o
16 fine chemopreventive activity, optimal dose, administration schedule, and toxicity for the coxibs in
17 g regimens are toxic, they require demanding administration schedules, and resistant viruses can emer
18     Treatment adherence, optimization of the administration schedule, anticoagulant prophylaxis, as w
19 owth inhibition/growth delay over a repeated administration schedule at well-tolerated doses.
20 th RAD001, a rapamycin derivative, showed an administration schedule-dependent increase in activation
21                                  With either administration schedule, dose escalation should be consi
22                           Two different dose administration schedules (Ex-Rad I administered 24 and 3
23 that identifies in silico the most effective administration schedule for gemcitabine monotherapy.
24                                 The standard administration schedule for most COVID-19 vaccines curre
25                                    The short administration schedule for the treatment of children wi
26 e trials aimed at identifying more effective administration schedules for doxycycline are warranted.
27 he emergence of resistance, and optimum drug administration schedules for patient populations at risk
28 ed significantly in dose, concentration, and administrations schedule for both hypertonic saline and
29                                   Parenteral administration schedules have been evaluated because of
30 ework significantly changes the optimum drug administration schedules identified, often predicting no
31                                   A flexible administration schedule improved the safety profile of t
32 ther antineoplastic agents in four different administration schedules in A549 human non-small cell lu
33 ility after oral and 2-hour intravenous (IV) administration schedules in patients with malignancy.
34                  Few practices changed their administration schedules in response to revised recommen
35 e agents, probiotics often require intensive administration schedules incurring difficult user adhere
36 d a bone marrow-sparing effect when a weekly administration schedule is used.
37 y, research barriers if the Drug Enforcement Administration schedules it, and alternatives for contin
38                                Switching and administration schedule of IFI was at the discretion of
39 study was undertaken to evaluate the optimum administration schedule of pemetrexed and gemcitabine in
40  determine the efficacy, safety, and optimal administration schedule of rituximab with fludarabine in
41                  Adoption of an intermittent administration schedule of this cytokine could be more e
42  million immunized children, but its current administration schedule of two doses given a year apart
43 -level phenomena can be used to optimize the administration schedules of concurrent radiation and tem
44 m-tolerated dose (MTD) of BMS-184476 on this administration schedule, only one heavily pretreated pat
45 ure periods were estimated using recommended administration schedules or drug elimination times.
46 ured) received lidocaine or saline on 1 of 4 administration schedules (preinjury only, postinjury onl
47 phase II evaluations of penclomedine on this administration schedule should be focused on specific di
48 re partially alleviated through altering the administration schedule to nighttime dosing.
49           The identification of optimal drug administration schedules to battle the emergence of resi
50                            MPO regardless of administration schedule (twice a day or every day) signi
51       In the present investigation, a longer administration schedule was used, which encompasses both
52                                    Docetaxel administration schedules were as follows: schedule A, on
53                                Two docetaxel administration schedules were studied, with the drug adm
54    These results highlight the importance of administration schedule when combining flavopiridol with